And so on, in patients with cancer, the pre-existence of the smPD-L1/PD-1 interaction on T cells inhibits DCs from priming T cells, which home to the lymph nodes from the peripheral blood, then traffic and infiltrate into the tumor microenvironment, and has their tumor cell-killing ability suppressed. The gene discussed is PDCD1; the disease is cancer.